CareFirst BlueCross BlueShield Welcomes Accomplished Physician and Public Health Advocate as Chief Medical Officer
26 avr. 2021 11h03 HE
|
CareFirst BlueCross BlueShield
Baltimore, Md., April 26, 2021 (GLOBE NEWSWIRE) -- CareFirst BlueCross BlueShield (CareFirst) has appointed Dr. Tich Changamire as their new Chief Medical Officer. Dr. Changamire brings more than 20...
ASLAN Pharmaceuticals Appoints Kenneth Kobayashi, MD, as Chief Medical Officer
03 août 2020 03h17 HE
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Aug. 03, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative...
Merus Appoints Andrew Joe, M.D., as Chief Medical Officer
27 juil. 2020 08h00 HE
|
Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific...
Innate Pharma Announces the Appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer
16 juil. 2020 01h00 HE
|
INNATE PHARMA
MARSEILLE, France, July 16, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the appointment of Dr....
MDLIVE Expands Leadership Team with Appointment of Cynthia Zelis, MD, MBA, as Chief Medical Officer
03 juin 2020 08h00 HE
|
MDLIVE Inc.
CHICAGO and MIRAMAR, Fla., June 03, 2020 (GLOBE NEWSWIRE) -- MDLIVE Inc. today announced the appointment of Cynthia Zelis, MD, MBA, as chief medical officer. A board-certified family physician and...
Emergent BioSolutions Appoints Dr. Karen L. Smith as Chief Medical Officer
21 avr. 2020 16h55 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., April 21, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Dr. Karen L. Smith, M.D., Ph.D. as chief medical officer with...
Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer
13 avr. 2020 16h30 HE
|
Cellectis Inc.
NEW YORK, April 13, 2020 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited...
Cybrexa Therapeutics Announces Arthur DeCillis, MD as Acting Chief Medical Officer to Support CBX-12’s Entry into the Clinic
31 mars 2020 08h00 HE
|
Cybrexa Therapeutics
NEW HAVEN, Conn., March 31, 2020 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting...
Morphic Announces Appointment of Peter G. Linde, M.D., as Chief Medical Officer
17 mars 2020 08h00 HE
|
Morphic Therapeutic
WALTHAM, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
Mujtaba Ali-Khan, D.O. Named Chief Medical Officer at HCA Gulf Coast Division
21 janv. 2020 10h26 HE
|
HCA Houston Healthcare
Houston, Jan. 21, 2020 (GLOBE NEWSWIRE) -- The HCA Gulf Coast Division has appointed Mujtaba Ali-Khan, D.O. to the position of chief medical officer for HCA Gulf Coast Division. Ali-Khan, who began...